Gene · 4025
LPO: lactoperoxidase
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. LPO: lactoperoxidase. Genes, record 4025. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/4025
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P22079 | Lactoperoxidase | 712 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents30
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 51051 | P22079 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 2045 | P22079 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 1610 | P22079 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 7977 | P22079 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 6915 | P22079 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 6915 | P22079 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 1610 | P22079 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 2045 | P22079 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 7977 | P22079 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 7977 | P22079 | Espacenet |
1 to 10 of 30
See all 30 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,050
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | LPO papers | Newest fiscal year |
|---|---|---|---|
| P30DK054759 | Precision Medicine Center for Cystic Fibrosis | 6 | 2025 |
| P30ES005605 | Environmental Health Sciences Research Center | 6 | 2025 |
| P42ES013661 | Iowa Superfund Research Program: Airborne PCBs: Sources, Exposures, Toxicities, Remediation | 5 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 4 | 2025 |
| R35GM124590 | Molecular Mechanisms of Bacterial Stress Response Relevant to Host-Microbe Interactions | 4 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| P30CA036727 | Buffett Cancer Center Support Grant | 3 | 2025 |
| P30DK020572 | Michigan Diabetes Research Center (MDRC) | 3 | 2025 |
| P30DK089503 | Michigan Nutrition Obesity Research Center | 3 | 2025 |
| ZIACP010135 | Studies of Non-Ionizing Radiation-Related Cancer | 3 | 2025 |
1 to 10 of 1,050Source NIH's project files
See all 1,050 nih grantsPapers2,897
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nanoparticle Shape-Templated Peptide Organization Enables Tunable Enhancement of Enzyme Activity. | ACS Appl Mater Interfaces | 2026 | 42809811 | PubTator, text mining | PubMed |
| The Endogenous Metabolite Hypochlorite Activates Indoleamine 2,3-Dioxygenase-1 for Catalysis: Functional and Mechanistic Implications. | Angew Chem Int Ed Engl | 2026 | 42809307 | PubTator, text mining | PubMed |
| Emerging roles of structural elements guiding human heme peroxidase function and interactions. | Biochim Biophys Acta Proteins Proteom | 2026 | 42759823 | PubTator, text mining | PubMed |
| Interface N-glycans drive myeloperoxidase dimerization in vitro. | Int J Biol Macromol | 2026 | 42735772 | PubTator, text mining | PubMed |
| Protein mediators of chronic kidney disease in Type 2 diabetes: A mendelian randomization study. | PLoS Med | 2026 | 42726788 | PubTator, text mining | PubMed |
| Proteomic insights into goat milk serum proteins at varying altitudes in China. | Food Chem X | 2026 | 42668543 | PubTator, text mining | PubMed |
| Discovery and Preclinical Characterization of NE-2-6 as a Potent Thyroid Peroxidase Inhibitor with Antithyroid Activity. | Antioxidants (Basel) | 2026 | 42650232 | PubTator, text mining | PubMed |
| Changes in saliva composition during different training phases in professional football players. | Front Dent Med | 2026 | 42620368 | PubTator, text mining | PubMed |
| Viscosity of Carboxymethylcellulose, Hydroxyethylcellulose and Polyethylene Glycol and Their Effect on Salivary Enzymes. | Int Dent J | 2026 | 42508216 | PubTator, text mining | PubMed |
| Enzyme-Based Mouthwashes for Oral Wound Healing and Xerostomia. | Eur J Dent | 2026 | 42419704 | PubTator, text mining | PubMed |
1 to 10 of 2,897
See all 2,897 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/4025
GET https://conductscience.org/api/genes/v1/4025/patents?page=2